XML 24 R5.htm IDEA: XBRL DOCUMENT v3.22.4
Consolidated Balance Sheets - USD ($)
$ in Millions
Dec. 31, 2022
Dec. 31, 2021
Current Assets    
Cash and cash equivalents $ 1,508 $ 536
Trade receivables - third party and affiliates 1,379 1,161
Non-trade receivables, net 675 506
Inventories 2,808 1,524
Other assets 241 80
Total current assets 6,611 3,807
Investments in affiliates 1,062 823
Property, plant and equipment (net of accumulated depreciation - 2022: $3,687; 2021: $3,484) 5,584 4,193
Operating lease right-of-use assets 413 236
Deferred income taxes 808 248
Other assets 547 521
Goodwill 7,142 [1] 1,412
Intangible assets, net 4,105 735
Total assets 26,272 11,975
Current Liabilities    
Short-term borrowings and current installments of long-term debt - third party and affiliates 1,306 791
Trade payables - third party and affiliates 1,518 1,160
Other liabilities 1,201 473
Income taxes payable 43 81
Total current liabilities 4,068 2,505
Long-term debt, net of unamortized deferred financing costs 13,373 3,176
Deferred income taxes 1,242 555
Uncertain tax positions 322 280
Benefit obligations 411 558
Operating lease liabilities 364 200
Other liabilities 387 164
Commitments and Contingencies
Shareholders' Equity    
Preferred stock, $0.01 par value, 100,000,000 shares authorized (2022 and 2021: 0 issued and outstanding) 0 0
Common stock, $0.0001 par value, 400,000,000 shares authorized (2022: 170,135,425 issued and 108,473,932 outstanding; 2021: 169,760,024 issued and 108,023,735 outstanding) 0 0
Treasury stock, at cost (2022: 61,661,493 shares; 2021: 61,736,289 shares) (5,491) (5,492)
Additional paid-in capital 372 333
Retained earnings 11,274 9,677
Accumulated other comprehensive income (loss), net (518) (329)
Total Celanese Corporation shareholders' equity 5,637 4,189
Noncontrolling interests 468 348
Total equity 6,105 4,537
Total liabilities and equity $ 26,272 $ 11,975
[1] There were no accumulated impairment losses as of December 31, 2022.